Kewaunee Scientific (KEQU) vs Exagen (XGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Kewaunee Scientific (KEQU) has outperformed Exagen (XGN) over the past year, losing 22.8% versus a loss of 25.6%. Over five years, KEQU leads with a +156.2% price change compared with -35.3% for XGN. Exagen is the larger company by market cap ($197.9 million vs $97.9 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | KEQU | XGN |
|---|---|---|
| Share price | $33.82 | $8.17 |
| Market cap | $97.92M | $197.92M |
| 1-day change | -0.06% | -1.57% |
| YTD return | -9.60% | +34.38% |
| 1-year return | -22.84% | -25.59% |
| 5-year return | +156.21% | -35.31% |
| P/E ratio (TTM) | 12.25 | — |
| Forward P/E | 15.66 | — |
| EPS (TTM) | $2.76 | $-0.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $46.57 | $12.23 |
| 52-week low | $32.00 | $2.59 |
| Distance from 52-week high | -27.38% | -33.20% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +24.11% |
| Average volume | 4.22K | 328.42K |
| Shares outstanding | 2.90M | 24.23M |
| Employees | 1,231 | 216 |
| Sector | Industrials | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Exagen is about 2.0 times larger than Kewaunee Scientific by market value ($197.92M vs $97.92M).
- The two companies sit in different sectors: Kewaunee Scientific in Industrials and Exagen in Health Care.
About Kewaunee Scientific
KEQU stock →Kewaunee Scientific Corporation, together with its subsidiaries, designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally. It operates through two segments, Lab Products Group (LPG) and International.
Industrials · Medical Specialities · 1,231 employees
About Exagen
XGN stock →Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Health Care · Medical Specialities · 216 employees
KEQU vs XGN FAQ
Which is bigger, Kewaunee Scientific or Exagen?
Exagen (XGN) is larger, with a market capitalization of $197.92M compared with $97.92M for Kewaunee Scientific (KEQU).
Which stock has performed better over the past year, KEQU or XGN?
KEQU returned -22.84% over the past 12 months, compared with -25.59% for XGN (price return, excluding dividends). Past performance does not predict future results.
Are Kewaunee Scientific and Exagen in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Industrials sector.